190 related articles for article (PubMed ID: 11486002)
21. Comparative simulation studies of native and single-site mutant human beta-defensin-1 peptides.
Toubar RA; Zhmurov A; Barsegov V; Marx KA
J Biomol Struct Dyn; 2013; 31(2):174-94. PubMed ID: 22830355
[TBL] [Abstract][Full Text] [Related]
22. Solution structure of bovine neutrophil beta-defensin-12: the peptide fold of the beta-defensins is identical to that of the classical defensins.
Zimmermann GR; Legault P; Selsted ME; Pardi A
Biochemistry; 1995 Oct; 34(41):13663-71. PubMed ID: 7577957
[TBL] [Abstract][Full Text] [Related]
23. Reconstruction of the conserved beta-bulge in mammalian defensins using D-amino acids.
Xie C; Prahl A; Ericksen B; Wu Z; Zeng P; Li X; Lu WY; Lubkowski J; Lu W
J Biol Chem; 2005 Sep; 280(38):32921-9. PubMed ID: 15894545
[TBL] [Abstract][Full Text] [Related]
24. A novel beta-defensin structure: big defensin changes its N-terminal structure to associate with the target membrane.
Kouno T; Mizuguchi M; Aizawa T; Shinoda H; Demura M; Kawabata S; Kawano K
Biochemistry; 2009 Aug; 48(32):7629-35. PubMed ID: 19588912
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological characterization of human beta-defensins 3 and 4 on potassium channels: Evidence of diversity in beta-defensin-potassium channel interactions.
Zhao Y; Xie Z; Feng J; Li W; Cao Z; Wu Y
Peptides; 2018 Oct; 108():14-18. PubMed ID: 30121363
[TBL] [Abstract][Full Text] [Related]
26. Interaction of human β-defensin 2 (HBD2) with glycosaminoglycans.
Seo ES; Blaum BS; Vargues T; De Cecco M; Deakin JA; Lyon M; Barran PE; Campopiano DJ; Uhrín D
Biochemistry; 2010 Dec; 49(49):10486-95. PubMed ID: 21062008
[TBL] [Abstract][Full Text] [Related]
27. Unique properties of human β-defensin 6 (hBD6) and glycosaminoglycan complex: sandwich-like dimerization and competition with the chemokine receptor 2 (CCR2) binding site.
De Paula VS; Pomin VH; Valente AP
J Biol Chem; 2014 Aug; 289(33):22969-22979. PubMed ID: 24970887
[TBL] [Abstract][Full Text] [Related]
28. Structural basis for the interaction of human β-defensin 6 and its putative chemokine receptor CCR2 and breast cancer microvesicles.
De Paula VS; Gomes NS; Lima LG; Miyamoto CA; Monteiro RQ; Almeida FC; Valente AP
J Mol Biol; 2013 Nov; 425(22):4479-95. PubMed ID: 23938203
[TBL] [Abstract][Full Text] [Related]
29. Preparation of isotopically labelled recombinant beta-defensin for NMR studies.
Seo ES; Vargues T; Clarke DJ; Uhrín D; Campopiano DJ
Protein Expr Purif; 2009 Jun; 65(2):179-84. PubMed ID: 19063971
[TBL] [Abstract][Full Text] [Related]
30. Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.
Patil AA; Cai Y; Sang Y; Blecha F; Zhang G
Physiol Genomics; 2005 Sep; 23(1):5-17. PubMed ID: 16033865
[TBL] [Abstract][Full Text] [Related]
31. Evolutionary selective trends of insect/mosquito antimicrobial defensin peptides containing cysteine-stabilized alpha/beta motifs.
Dassanayake RS; Silva Gunawardene YI; Tobe SS
Peptides; 2007 Jan; 28(1):62-75. PubMed ID: 17161505
[TBL] [Abstract][Full Text] [Related]
32. Toward full-sequence de novo protein design with flexible templates for human beta-defensin-2.
Fung HK; Floudas CA; Taylor MS; Zhang L; Morikis D
Biophys J; 2008 Jan; 94(2):584-99. PubMed ID: 17827237
[TBL] [Abstract][Full Text] [Related]
33. The synthetic peptides bovine enteric β-defensin (EBD), bovine neutrophil β-defensin (BNBD) 9 and BNBD 3 are chemotactic for immature bovine dendritic cells.
Mackenzie-Dyck S; Attah-Poku S; Juillard V; Babiuk LA; van Drunen Littel-van den Hurk S
Vet Immunol Immunopathol; 2011 Sep; 143(1-2):87-107. PubMed ID: 21764462
[TBL] [Abstract][Full Text] [Related]
34. Electrostatic Similarity Analysis of Human β-Defensin Binding in the Melanocortin System.
Nix MA; Kaelin CB; Palomino R; Miller JL; Barsh GS; Millhauser GL
Biophys J; 2015 Nov; 109(9):1946-58. PubMed ID: 26536271
[TBL] [Abstract][Full Text] [Related]
35. Artificial beta-defensin based on a minimal defensin template.
Antcheva N; Morgera F; Creatti L; Vaccari L; Pag U; Pacor S; Shai Y; Sahl HG; Tossi A
Biochem J; 2009 Jul; 421(3):435-47. PubMed ID: 19453294
[TBL] [Abstract][Full Text] [Related]
36. Simulating the antimicrobial mechanism of human β-defensin-3 with coarse-grained molecular dynamics.
Zhao X; Yu H; Yang L; Li Q; Huang X
J Biomol Struct Dyn; 2015; 33(11):2522-9. PubMed ID: 25562440
[TBL] [Abstract][Full Text] [Related]
37. Structure-dependent charge density as a determinant of antimicrobial activity of peptide analogues of defensin.
Bai Y; Liu S; Jiang P; Zhou L; Li J; Tang C; Verma C; Mu Y; Beuerman RW; Pervushin K
Biochemistry; 2009 Aug; 48(30):7229-39. PubMed ID: 19580334
[TBL] [Abstract][Full Text] [Related]
38. A hybrid cationic peptide composed of human β-defensin-1 and humanized θ-defensin sequences exhibits salt-resistant antimicrobial activity.
Olli S; Nagaraj R; Motukupally SR
Antimicrob Agents Chemother; 2015 Jan; 59(1):217-25. PubMed ID: 25348533
[TBL] [Abstract][Full Text] [Related]
39. Detection of beta-defensins secreted by human oral epithelial cells.
Diamond DL; Kimball JR; Krisanaprakornkit S; Ganz T; Dale BA
J Immunol Methods; 2001 Oct; 256(1-2):65-76. PubMed ID: 11516756
[TBL] [Abstract][Full Text] [Related]
40. Evolutionary origin of β-defensins.
Zhu S; Gao B
Dev Comp Immunol; 2013; 39(1-2):79-84. PubMed ID: 22369779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
